MLNT
Dimensional Fund Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-98,622
| Closed | -$52K | – | 3434 |
|
|
2019
Q4 | $52K | Sell |
98,622
-110,392
| -53% | -$58.2K | ﹤0.01% | 3346 |
|
|
2019
Q3 | $796K | Buy |
209,014
+12,362
| +6% | +$47.1K | ﹤0.01% | 3054 |
|
|
2019
Q2 | $1.31M | Buy |
196,652
+41,338
| +27% | +$275K | ﹤0.01% | 2995 |
|
|
2019
Q1 | $551K | Sell |
155,314
-617,411
| -80% | -$2.19M | ﹤0.01% | 3150 |
|
|
2018
Q4 | $613K | Buy |
772,725
+48,907
| +7% | +$38.8K | ﹤0.01% | 3112 |
|
|
2018
Q3 | $2.86M | Buy |
723,818
+182,235
| +34% | +$720K | ﹤0.01% | 2836 |
|
|
2018
Q2 | $3.44M | Buy |
541,583
+65,371
| +14% | +$415K | ﹤0.01% | 2747 |
|
|
2018
Q1 | $3.52M | Buy |
476,212
+45,784
| +11% | +$339K | ﹤0.01% | 2731 |
|
|
2017
Q4 | $6.8M | Buy |
+430,428
| New | +$6.8M | ﹤0.01% | 2511 |
|